Page last updated: 2024-11-02

phenylbutazone and Hyperkalemia

phenylbutazone has been researched along with Hyperkalemia in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Deventer, SJ1
Statius van Eps, LW1

Reviews

1 review available for phenylbutazone and Hyperkalemia

ArticleYear
[Acute kidney function disorders caused by nonsteroidal anti-inflammatory agents].
    Nederlands tijdschrift voor geneeskunde, 1986, Apr-19, Volume: 130, Issue:16

    Topics: Anti-Inflammatory Agents; Anuria; Diuresis; Humans; Hyperkalemia; Kidney; Kidney Diseases; Natriures

1986